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ABSTRACT
Background and Objectives: Advances in endoscopic
techniques have transformed the management of urolithi-
asis. We sought to evaluate the role of such urological
interventions for the treatment of complex biliary calculi.
Methods: We conducted a retrospective review of all
patients (n9) undergoing percutaneous holmium laser
lithotripsy for complicated biliary calculi over a 4-year
period (12/2003 to 12/2007). All previously failed standard
techniques include ERCP with sphincterotomy (n6),
PTHC (n7), or both of these. Access to the biliary system
was obtained via an existing percutaneous transhepatic
catheter or T-tube tracts. Endoscopic holmium laser lith-
otripsy was performed via a flexible cystoscope or uret-
eroscope. Stone clearance was confirmed intra- and post-
operatively. A percutaneous transhepatic drain was left
indwelling for follow-up imaging.
Results: Mean patient age was 65.6 years (range, 38 to
92). Total stone burden ranged from 1.7 cm to 5 cm. All 9
patients had stones located in the CBD, with 2 patients
also having additional stones within the hepatic ducts. All
9 patients (100%) were visually stone-free after one endo-
scopic procedure. No major perioperative complications
occurred. Mean length of stay was 2.4 days. At a mean
radiological follow-up of 5.4 months (range, 0.5 to 21), no
stone recurrence was noted.
Conclusions: Percutaneous endoscopic holmium laser
lithotripsy is a minimally invasive alternative to open
salvage surgery for complex biliary calculi refractory to
standard approaches. This treatment is both safe and
efficacious. Success depends on a multidisciplinary ap-
proach.
Key Words: Biliary calculi, Holmium laser, Endoscopic,
Lithotripsy.
INTRODUCTION
Gallstone disease is a common and costly health problem
in the Western world. In the United States alone, the
incidence rate for cholelithiasis is 10% to 20%, and over
600,000 cholecystectomies are performed annually. The
disease course may be complicated by the presence of
stones within the common bile duct (CBD), or chole-
docholithiasis.1 Although choledocholithiasis is typically
due to infectious causes in Asian populations, most cases
in the West develop as a secondary result of calculi orig-
inating in the gallbladder or stones resulting from benign
strictures, sclerosing cholangitis, choledochal cysts, or ma-
lignant biliary tumors.2 In fact, secondary choledocholithi-
asis complicates between 10% and 15% of cases of cho-
lelithiasis in the United States.1,3
The goal of treatment is to clear obstructing biliary calculi
by using the minimum number of procedures with the
lowest risk of morbidity. Currently, most biliary calculi are
successfully removed either at the time of laparoscopic
cholecystectomy or pre- or postoperatively with endo-
scopic retrograde cholangiopancreatography (ERCP) or
transhepatic cholangiography (PTHC).4,5 Infrequently,
these approaches fail and traditional open salvage proce-
dures such as open CBD exploration are required to
extract retained biliary stones. Patients with complex bil-
iary calculi pose a unique challenge, particularly because
they are often debilitated with multiple comorbidities.
Technologies well proven for the treatment of urinary
calculi may prove useful in managing complicated biliary
calculi. More specifically, holmium:yttrium aluminum gar-
net laser (Ho:YAG) lithotripsy is a safe and effective min-
imally invasive technique that has revolutionized the man-
agement of urolithiasis. The purpose of this study was to
evaluate our preliminary experience with holmium:YAG
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SCIENTIFIC PAPERlaser lithotripsy in the management of complicated biliary
tract calculi.
MATERIALS AND METHODS
Between December 2003 and December 2007, 9 patients
(4 men, 5 women) were referred to the Urology service for
management of biliary calculi refractory to standard tech-
niques. Patient demographic and clinical data are summa-
rized in Table 1. Mean age was 65.6 years (range, 38 to
92). Two patients had CBD and hepatic stones following
orthotopic liver transplantation. Two patients had retained
CBD stones after cholecystectomy. Two patients pre-
sented initially with obstructive hyperbilirubinemia due to
CBD calculi. One patient had undergone multiple prior
ERCPs and even open exploration for a CBD stone. One
patient had a CBD stone following a Whipple procedure
and hepatojejunostomy. Lastly, one patient had multiple
hepatic and CBD calculi secondary to primary sclerosing
cholangitis (PSC). All 9 patients had previously failed
ERCP with sphincterotomy6 or PTHC,7 or both, with at-
tempted stone extraction. These standard techniques had
failed due to inaccessibility, large stone burdens, anatomic
abnormalities, or all of these. Urological intervention was
chosen as an alternative to an open salvage surgical pro-
cedure. Percutaneous transhepatic endoscopic stone ma-
nipulation was performed as a combined procedure be-
tween the Interventional Radiology (AC and LM) and
Urology (PN and KO) departments.
All patients had stones located in the CBD, with 2 patients
also having additional stones within the hepatic ducts.
Five patients presented with multiple stones while 4 pa-
tients had solitary stones. Total stone burden ranged from
1.7 cm to 5 cm. All patients had an existing percutaneous
transhepatic drain (8 Fr to 14 Fr) in place from 2 days to 15
years prior to endoscopic intervention. The tracts were
sequentially dilated under fluoroscopic guidance to be-
tween 14 Fr and 20 Fr to accommodate either a flexible
cystoscope (6) or ureteroscope (3). Lithotripsy was per-
formed under direct endoscopic vision by using a hol-
mium laser ranging in size from 200 mt o5 0 0m,
depending on stone burden, stone location, and choice of
endoscope (cystoscope versus ureteroscope). Laser fre-
quency ranged between 6 Hz and 10 Hz, generating 0.6
joules to 1.0 joules of energy. Stone fragments and debris
were either flushed into the duodenum (9) or basket
extracted (3) from the biliary tree (Figure 1), or both. In
one case, multiple stones were small enough to basket
Table 1.
Patient Demographic and Clinical Data
Patient Age (yrs) Sex Indication Stone Location† Prior Intervention(s)† # Stones Stone Burden
(om)
1 78 F s/p Whipple with
hepatojejunostomy
CBD PTHC 1 4
2 79 F Large CBD calculi,
stricture
CBD ERCP, PTHC Multiple 1.7*
3 56 F s/p Orthotopic liver
transplant
Hepatic, CBD ERCP, PTHC Multiple 4-5
4 68 M CBD stenosis s/p
cholecystectomy
CBD PTHC (multiple) 3 4.5
5 69 M Retained CBD calculi s/p
cholecystectomy
CBD ERCP (2), PTHC 3 4
6 38 M s/p Orthotopic liver
transplant
CBD PTHC 1 3
7 52 M Primary sclerosing
cholangitis
Hepatic, CBD ERCP, PTHC Multiple 5
8 58 F Large CBD calculus CBD ERCP (multiple), open CBDE 1 3
9 92 F Large CBD calculus,
stricture
CBD ERCP (multiple), PTHC (multiple) 1 2.3
*Denotes size of largest calculus.
†CBD  Common bile duct, ERCP  endoscopic retrograde cholangiopancreatography, PTHC  transhepatic cholangiography.
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laser lithotripsy.
Following endoscopic stone treatment, all patients had
antegrade passage of a Fogarty balloon over a guide wire
into the duodenum to expel any remaining CBD calculi.
Finally, endoscopic inspection of the biliary system was
performed to verify that no stone fragments remained. At
the conclusion of the procedure, a percutaneous transhe-
patic drain (12 Fr to 14 Fr) was left indwelling for fol-
low-up cholangiography.
Success was defined as symptom relief, “stone-free” status
of the biliary tree on final endoscopic inspection, and lack
of residual stone fragments visualized on follow-up imag-
ing, including antegrade cholangiography, computed to-
mography (CT) scans, or both (Figure 2).
RESULTS
All 9 (100%) patients were visually “stone-free” at the
conclusion of one percutaneous transhepatic endoscopic
procedure. Importantly, postprocedure endoscopic in-
spection of the CBD also showed no evidence of mucosal
injury. At a mean radiological follow-up of 5.4 months
(range, 0.5 to 21), there was no evidence of stone recur-
rence. Of the total 9 patients, 4 (44.4%) were drain-free
and another 4 (44.4%) tolerated capping of their biliary
drain. One patient necessitated persistent postoperative
biliary drainage secondary to CBD stenosis following cho-
lecystectomy. At last follow-up, cholangioplasty was
aborted due to the patient experiencing oxygen desatura-
tion and coding during cholangiography.
The majority of patients were discharged from the hospital
24 hours to 48 hours after lithotripsy (mean LOS 2.4 days).
Two patients had extended hospital stays of 7 days after
surgery secondary to comorbid conditions, not associated
with the surgical procedure itself. No major perioperative
complications occurred. However, one patient with a his-
tory of recurrent cholangitis expired 4 weeks postopera-
tively due to sepsis. As aforementioned, a second patient
coded from narcosis during follow-up cholangiography 2
weeks postoperatively. This patient recovered unevent-
fully without adverse sequelae. Lastly, a third patient de-
veloped urinary retention following the procedure.
DISCUSSION
The majority of CBD stones are managed endoscopically
with sphincterotomy and stone extraction (with or with-
out fragmentation), performed before or after laparo-
scopic cholecystectomy.4 Alternatively, laparoscopic CBD
exploration and stone extraction may be performed at the
time of cholecystectomy. In a review of the literature, the
reported median success rate for sphincterotomy is ap-
Figure 1. (A) Endoscopic view of large common bile duct calculi. (B)
After holmium laser lithotripsy, intraductal irrigation and Fogarty bal-
loon were used to expel stone fragments into the duodenum.
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rate 8% (range, 2% to 24%), and mortality rate 1% (range,
0% to 6%).5 Similarly, laparoscopic CBD exploration re-
sults in bile duct clearance rates 90% in 70% of reports,
with a median retained stone rate of 5% (range, 0% to
19%). The median complication rate is 8% (range, 2% to
17%) and the mortality rate is 1% (range, 0% to 5%).5,6
Finally, open CBD exploration is typically reserved for
patients who are not candidates for endoscopic or lapa-
roscopic procedures. However, open exploration is not
fraught without associated morbidity. In a recent study by
Livingston et al,7 complication rates for open CBD explo-
ration rose from 3.4% in 1993 to an alarmingly high 17.4%
in 2001, possibly due to decreasing open surgeon expe-
rience in the laparoscopic era.
While advances in endoscopy and laparoscopy have
transformed the management of choledocholithiasis, ad-
vances in urological techniques have similarly revolution-
ized the treatment of urolithiasis over the past several
decades. Stones that were previously managed with open
surgery, shock wave lithotripsy, or “blind” fluoroscopic
basketing can now be directly accessed endoscopically
and treated with laser lithotripsy. This is now possible due
to the miniaturization of flexible endoscopes and the
widespread availability of the holmium laser. The hol-
mium laser is a small contact lithotrite (200 m to 1000
m) that effectively fragments urinary stones with mini-
mal stone retropulsion and subsequent collateral damage
to surrounding tissue. Additionally, the flexible composi-
tion of the laser fibers provides little impedance to the
deflection of ureteroscopes, thereby facilitating access to
the entire urinary system. Moreover, the holmium laser is
capable of fragmenting even the hardest stones that are
oftentimes resistant to other lithotrites.
The success of holmium laser lithotripsy in the manage-
ment of urinary calculi has led several investigators to
apply this technology to complex biliary calculi resistant
to standard treatments. A few case reports have demon-
strated the clinical efficacy of the holmium laser using
percutaneous access techniques in patients with compli-
cated bile duct stones. Tarman et al8 documented the
utility of intracorporeal lithotripsy in a case of intrahepatic
biliary stones. Monga et al9 described a complex case of
biliary obstruction that developed 7 years following a
Roux-en-Y choledochojejunostomy. The holmium laser
was used to completely fragment the stones via the per-
cutaenous transhepatic route. Several small series have
further validated the usefulness of holmium laser litho-
tripsy for the treatment of difficult biliary calculi. Das et
al10 effectively managed 4 patients who presented with
sepsis associated with stones in the gallbladder (n2) or
bile duct (n2). In a series of 3 patients, Teichman et al11
documented successful clearance of difficult CBD stones
using the holmium laser in a single therapeutic setting. Of
note, no complications developed, and all patients re-
mained free of recurrence during a 6-month follow-up
period.
Subsequently, Ponsky et al12 reviewed their experience
with 14 patients who were treated with contemporary
“urologic” intervention for refractory pancreaticobiliary
calculi. Five of these patients underwent percutaneous
Figure 2. (A) Preoperative antegrade cholangiogram reveals
common bile duct calculi. (B) Postoperative cholangiogram con-
firms successful holmium laser lithotripsy.
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mium laser lithotripsy, or basket extraction of hepatic duct
stones. All were rendered stone-free. However, 2 patients
required a “second look” percutaneous transhepatic
cholangiography or cholangioscopy, at which time small
residual fragments were extracted or flushed into the du-
odenum. Overall, the authors achieved a high success rate
of 86% for secondary urologic procedures in this compli-
cated cohort of pancreaticobiliary stone patients.
Shamamian and Grasso2 reported a much larger series of
36 patients with complex intrahepatic biliary calculi
treated with percutaneous endoscopic holmium laser lith-
otripsy. In their study, 22 patients of Asian descent had
primary intrahepatic calculi and 14 patients had secondary
intrahepatic calculi. Complete stone clearance was accom-
plished in all patients after an average of 3.9 (range, 1 to
15) and 2.6 procedures (range, 1 to 10) for those with
primary and secondary intrahepatic calculi, respectively.
No major complications occurred. No patient required
open bile duct exploration or hepatic resection.
Most recently, Hazey et al13 retrospectively reviewed 13
non-Asian patients with complex secondary biliary calculi
treated percutaneously using holmium laser lithotripsy.
Mean age was 69 years, and 3 of the 13 patients were
treated solely as outpatients. Stone clearance required an
average of 1.6 treatments per patient, and no patient
underwent greater than 3 treatments. Of note, 8 of the 13
patients required only a single holmium laser treatment to
clear their calculi. Average length of percutaneous access
was 108 days. Notably, only one patient developed pain
and required hospital admission. Based on their experi-
ence, the authors concluded that holmium laser ablation is
safe and efficacious for biliary calculi but may require
prolonged biliary access and several procedures.
Our cohort of patients had large, complex biliary calculi
that were effectively managed endoscopically through the
coordinated efforts of the Interventional Radiology and
Urology teams. Consistent with prior studies, we report a
uniformly high success rate in a single therapeutic setting
despite failed prior attempts at stone extraction. Com-
pared with most kidney stones, we found biliary calculi to
fragment easily with the holmium laser at low power
settings.
Although we did not analyze stone fragments to deter-
mine composition, several authors have reported ade-
quate fragmentation regardless of stone composition.
Shamamian and Grasso2 noted that the holmium laser was
capable of delivering sufficient energy to fragment stones
containing mixed combinations of cholesterol, calcium
bilirubinate, and mixed bile pigments.
As we have gained increasing experience with these
cases, several technical points warrant discussion. First,
the use of a flexible cystoscope compared with a flexible
ureteroscope allows for better maneuverability in what
can be a complex and capacious biliary system. In addi-
tion, improved cystoscopic visualization is important
when targeting stones in a system filled with bile. The
cystoscope allows for the passage of larger instruments,
specifically the use of larger 500-m holmium laser fibers
for laser lithotripsy. However, one caveat to using the
larger endoscope is the need for a larger diameter work-
ing sheath. To place a 16 Fr sheath, which is necessary
to accommodate our flexible cystoscope (15 Fr), a prior
percutaneous biliary tube must have been placed preop-
eratively for a period of at least 4 to 6 weeks. Failure to do
so places the patient at risk for potential liver fracture and
significant hemorrhage during tract dilation. No patients in
our series had any bleeding complications secondary to
sheath placement or stone manipulation. Conversely, a 12
Fr sheath may be used with the flexible ureteroscope
(range, 7 Fr to 9 Fr), which is our preference for patients
with a small stone burden.
Secondly, the anesthesia and operating room team must
institute measures to prevent postoperative complications
in this often debilitated patient population. Many patients
present with recurrent cholangitis from complicated bili-
ary calculi. Therefore, culture-specific intravenous antibi-
otics are given at least 24 hours before surgery and con-
tinued postoperatively while the patient is hospitalized.
Additionally, at the conclusion of the case, we directly
instill a fluoroquinolone antibiotic into the CBD via the
working sheath.
Finally, intraductal irrigation proved to be useful in flush-
ing stone fragments clear from the field. Because large
amounts of fluid are instilled into the CBD and subse-
quently the duodenum, we only use warmed normal sa-
line for irrigation to prevent hypothermia and hyponatre-
mia. Moreover, an orogastric tube is placed at the
beginning of the case to help prevent fluid overload.
Collectively, these perioperative maneuvers help mini-
mize complications during this surgical procedure.
CONCLUSION
Percutaneous endoscopic holmium laser lithotripsy is a safe
and efficacious minimally invasive treatment option for com-
plex biliary calculi refractory to standard modalities, which
Percutaneous Endoscopic Holmium Laser Lithotripsy for Management of Complicated Biliary Calculi, Healy K et al
JSLS (2009)13:184–189 188would otherwise necessitate an open salvage surgical pro-
cedure. Though traditionally used for urological procedures,
flexible endoscopes and the holmium laser are also well
suited for the treatment of stones in the biliary tree. Success
depends on a multidisciplinary approach.
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